intravitreal injection of ranibizumab

DRUG9 trials

Conditions

Diabetic Macular EdemaDiabetic RetinopathyEye DiseasesIntravitrealNon-Ischemic Central Retinal Vein Occlusion With Macular EdemaProliferative Diabetic RetinopathyRanibizumabRetinopathy of Prematurity

Phase 1

Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)

NCT00993525

University of Sao PauloProliferative Diabetic Retinopathy

Start: 2008-09-30End: 2010-03-31Target: 22Updated: 2009-10-12

Phase 2

Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion

CompletedNCT00815360

Retina Associates of Florida, P.A.Diabetic Macular Edema

Start: 2008-02-29End: 2011-08-31Updated: 2015-03-05

Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization

WithdrawnNCT00930189

Asociación para Evitar la Ceguera en MéxicoSubfoveal Choroidal Neovascularization

Start: 2006-04-30End: 2006-09-30Updated: 2024-05-30

Phase 3

Intravitreal injection versus medical treatment for acute CSR

Active, not recruitingPACTR202204601902304

Suez Canal University HospitalEye Diseases

Start: 2021-11-01Target: 45Updated: 2026-08-03

Phase 4

Ranibizumab Versus Aflibercept for CRVO in Young Patients.

NCT05282420

South Valley UniversityNon-Ischemic Central Retinal Vein Occlusion With Macular Edema

Start: 2021-02-01End: 2022-05-31Target: 40Updated: 2022-03-16

Unknown Phase

Evaluation of Ranibizumab for diabetes macular edema

Active, not recruitingJPRN-UMIN000001984

Yamagata University faculty of Medecine,department of ophthalmologydiabetes macular edema

Start: 2009-05-01Target: 10Updated: 2026-06-29

Intravitreal injection of anti vascular endothelial growth factor agent, Lucentis (ranibizumab), for the treatment of retinopathy of prematurity

Active, not recruitingJPRN-UMIN000013975

Nagoya University hospital ophtalmoligyretinopathy of prematurity

Start: 2014-07-01Target: 30Updated: 2026-06-29

Intravitreal Ranibizumab in Recurrent ROP

CompletedNCT04539106

Ameera Gamal AbdelhameedRetinopathy of Prematurity

Start: 2019-06-01End: 2020-02-01Updated: 2020-09-04

Subfoveal Choroidal Thickness and Visual Acuity After Intravitreal Injection of Ranibizumab in Diabetic Retinopathy

CompletedNCT06173245

Egyptian Biomedical Research NetworkDiabetic Retinopathy, Intravitreal, Ranibizumab +2

Start: 2021-02-01End: 2023-02-01Updated: 2023-12-15